Sign In
Buy ATI
$179.94
+1.46 (+0.82%)
At Close: Jun 03, 2026
Allegheny Technologies (ATI) Increases Despite Market Slip: Here's What You Need to Know
07:06pm, Thursday, 19'th Dec 2024
Allegheny Technologies (ATI) concluded the recent trading session at $54.23, signifying a +0.04% move from its prior day's close.
Applied Optoelectronics Filed a Patent Infringement Lawsuit Against Accelight Technologies, Inc. (ATI)
04:10pm, Tuesday, 17'th Dec 2024
SUGAR LAND, Texas, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (“AOI”) (Nasdaq: AAOI), a leading provider of fiber-optic access network products for the internet datacenter, ca
BOLINGBROOK, Ill. , Dec. 17, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (OTCMKTS: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United State
New Strong Sell Stocks for December 4th
04:35am, Wednesday, 04'th Dec 2024
ATI, ARLP and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 4, 2024.
ATI Physical Therapy Receives Delisting Notice From the New York Stock Exchange
04:55pm, Tuesday, 03'rd Dec 2024
BOLINGBROOK, Ill. , Dec. 3, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (NYSE: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, to
New Strong Sell Stocks for December 2nd
05:31am, Monday, 02'nd Dec 2024
ATI, ATS and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 2, 2024.
New Strong Sell Stocks for November 22nd
04:56am, Friday, 22'nd Nov 2024
ATI, AKBA and ALTG have been added to the Zacks Rank #5 (Strong Sell) List on November 22, 2024.
New Strong Sell Stocks for November 18th
05:05am, Monday, 18'th Nov 2024
ATI, BALY and KOF have been added to the Zacks Rank #5 (Strong Sell) List on November 18, 2024.
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
07:15am, Thursday, 14'th Nov 2024
Overwhelming shareholder support in favour of take-private transaction with Aditxt Studies presented at IDWeek 2024™ demonstrate ATI-1701 provides full protection against lethal tularemia in animal
The Achievement Continues the Company's Streak in Earning the Rating Annually Since the Program Debuted in 2019 BOLINGBROOK, Ill. , Nov. 13, 2024 /PRNewswire/ -- ATI Physical Therapy ("ATI" or the "
ATI announces sale of precision rolled strip operations to Ulbrich
04:45pm, Wednesday, 06'th Nov 2024
Sharpens focus on strategic aerospace and defense markets, streamlines operations DALLAS , Nov. 6, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) announced it completed the sale of its precision rolled str
ATI Physical Therapy Reports Third Quarter 2024 Results
04:05pm, Monday, 04'th Nov 2024
BOLINGBROOK, Ill. , Nov. 4, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (NYSE: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, t
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
07:15am, Thursday, 31'st Oct 2024
Demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies Appili provides update on Aditxt transaction and encourages shareholders to vote their shares as soon as possible for the N
ATI's Earnings Miss Estimates in Q3, Revenues Increase Y/Y
08:10am, Wednesday, 30'th Oct 2024
ATI saw higher year-over-year sales in aerospace and defense in the third quarter.
ATI Inc (ATI) Q3 2024 Earnings Call Transcript
12:09pm, Tuesday, 29'th Oct 2024
ATI Inc (NYSE:ATI ) Q3 2024 Results Conference Call October 29, 2024 8:30 AM ET Company Participants David Weston - Vice President of Investor Relations Kim Fields - President, CEO & Director Don Newm
